Phonexia’s acquisition is not mainly a story about whether a Czech company sold for more or less than a comparable US business. It is a story about how specialised research in Brno became a global technology company — and why a South Korean investor saw room to take it further.
In late 2025, South Korea-based Crescendo Equity Partners acquired Phonexia, a Czech developer of voice biometrics and speech recognition software. The purchase price was not disclosed, and it is not the most useful measure of the transaction.
The more important facts are what already existed before the acquisition: almost two decades of specialised research and product development, customers in more than 60 countries, a portfolio designed for sensitive on-premises deployments, and an active relationship with Brno University of Technology.
The new owner did not buy an idea waiting to become a company. It acquired a working Czech deep-tech business with proprietary products, experienced people and international customers — but also with markets it had not yet fully developed.
That combination is worth examining for investors and technology companies looking at Czechia.
From university research to a global product company
Phonexia was founded in 2006 by six members of the Speech@FIT research group at the Faculty of Information Technology of Brno University of Technology.
The original purpose was practical. Research results had to be converted into software that met industry requirements, ran on standard hardware and could be integrated into customers’ systems. Early products used technology licensed from the university, while cooperation between the company and academic researchers continued as the business developed.
Today, Phonexia describes itself as a European provider of on-premises voice biometrics and speech recognition software. Its technologies include speaker identification, speech-to-text, language identification, speech translation and voice deepfake detection. The company says its current platform can work with more than 100 types of voice deepfake and supports speech-to-text in more than 60 languages.
These are not only consumer-facing AI features. Phonexia’s software is used in environments where data security, integration and dependable performance matter: government, intelligence, law enforcement, financial services and enterprise systems.
The company has remained relatively compact. Phonexia currently presents a team of more than 40 people serving customers in over 60 countries. This is precisely what makes the case interesting. A Czech technology company does not need thousands of employees to develop a narrow capability that matters internationally.
Why Crescendo was a strategic fit
Phonexia’s owners began looking for a buyer in 2024. According to JIC, the Brno innovation agency that had supported the company since its early years, the process started with roughly 200 potential buyers and narrowed to seven serious candidates.
The final choice was not described as a simple auction for the highest immediate price. The sellers wanted a technology-focused owner that could provide capital, understand the products and preserve what already worked inside the company.
Crescendo brought a relevant Asian investment perspective. Phonexia had already built a strong position in government and security applications, but further growth required more resources for research, commercial development and entry into additional markets. The company specifically identified Asia and the Middle East as regions where voice deepfake fraud is creating demand for better detection.
This created a credible match:
- Phonexia brought European research, proprietary speech technology and an established international customer base.
- Crescendo brought growth capital, experience with technology businesses and stronger access to Asian markets.
- Both sides saw value in developing the company rather than dismantling it or absorbing its products into an unrelated portfolio.
The acquisition therefore connects two different strengths: Czech engineering depth and South Korean capacity to scale technology businesses in Asia.
How Phonexia operates after the acquisition
The public evidence points to continuity rather than a rapid integration into the investor’s identity.
Phonexia still operates from Brno under its own brand. Its website continues to list Markéta Lőrinczy as CEO and Zuzana Roznosová as Co-CEO, alongside the existing product and technology leadership. The company continues to present its voice biometrics, forensic speaker identification, speech recognition and deepfake detection products directly to partners and customers.
The relationship with Brno University of Technology also remains important. During the sale process, the founders explicitly said they wanted the new owner to preserve and potentially strengthen the company’s research ties with the university. Phonexia remains listed as a university partner, and cooperation has included research into synthetic voice and deepfake detection.
The practical model is therefore straightforward:
- Phonexia remains the operating technology company in Brno.
- Its existing management and specialist team continue to develop and sell the products.
- Crescendo provides ownership, capital and a platform for faster international growth.
- The next phase places more emphasis on commercial customers, new sectors and Asian and Middle Eastern markets.
It is still too early to judge the long-term outcome. But the stated direction is clear: preserve the technical base in Czechia and use new resources to expand its reach.
What this reveals about Czech deep-tech opportunities
Phonexia is one company, not proof that every Czech university spin-off is ready for acquisition. It does, however, illustrate several features that international investors can find in Czechia.
Strong technology may sit inside a small organisation
Headcount is a poor shortcut for judging a specialist company. A compact team can hold valuable intellectual property, technical knowledge and customer relationships when it has spent years solving one difficult problem.
This is particularly relevant in fields such as cybersecurity, speech technology, electron microscopy, industrial software, semiconductor design and scientific instrumentation. Czech companies in these areas may be less visible than larger US competitors while still serving demanding international customers.
Universities can be part of the commercial ecosystem
The Phonexia story did not begin with a generic startup concept. It began with a research group that had already built specialised expertise and needed a commercial structure to bring it into industry.
For an investor, the university relationship can provide more than a line in the company history. It may support recruitment, continuing research, independent technical credibility and access to a wider specialist community.
Brno is particularly relevant here because its technology ecosystem combines universities, research groups, established international employers and local organisations such as JIC. The opportunity is not simply “cheap engineering”. It is access to accumulated knowledge and networks that are difficult to recreate quickly.
Patient companies may need a scaling partner
Many Czech technology businesses grow carefully from revenue rather than large rounds of venture capital. That discipline can produce a real product and a stable customer base, but it can also limit the speed of expansion.
For the right strategic or financial investor, this creates a specific opportunity: not funding an untested concept, but helping a proven company invest faster in sales, product development, certifications, integrations or new markets.
The investor’s role must fit the company’s needs. Capital alone is not enough if the owner does not understand the technology, the sales cycle or the value of keeping the local team intact.
Czechia can connect Asian capital with European technology
Phonexia also demonstrates that Czech–Asian business cooperation does not have to begin with a new factory.
A South Korean investor can enter Czechia by acquiring and developing an existing technology company. A Japanese or Taiwanese business can form a research partnership, invest in a specialist supplier, open an engineering centre or use Czechia as a base for European integration and customer support.
These models require less attention to headline size and more attention to strategic fit. The central question is whether the Czech capability solves a problem the investor understands and can help commercialise.
How to assess a similar opportunity in Czechia
Foreign investors and technology groups should look beyond company databases and financial multiples. A useful first assessment includes six areas:
- Technical evidence: What does the product do, how has it been tested, and which claims can be independently verified?
- Customer quality: Are customers using the technology in real operations, and how concentrated is the revenue?
- Intellectual property: Who owns the code, models, patents, licences and university-originated technology?
- Team continuity: Which founders, researchers, product leaders and salespeople are essential after a transaction?
- Scaling constraint: Is growth limited by capital, market access, regulation, certification, integrations or management capacity?
- Local ecosystem: Which university, research, public-sector and commercial relationships should be preserved?
Phonexia’s sale process offers one more practical lesson. Technical due diligence matters. JIC reports that the buyer engaged an external company to examine the quality of Phonexia’s products, alongside the financial and legal review. Deep tech should not be assessed only through presentations and revenue forecasts.
The opportunity is capability, not a discount
Comparing a Czech acquisition with a much larger US transaction may create an eye-catching headline, but it can hide the information an investor actually needs.
Companies differ in revenue, distribution, customer concentration, intellectual property, product breadth, growth rate and strategic value to a particular buyer. A lower transaction value does not automatically mean that the underlying engineering is weak or that a company was sold too cheaply.
The more useful conclusion from Phonexia is that Czechia contains specialised businesses whose global relevance may be greater than their local visibility. Finding them requires technical understanding, local relationships and patience. Developing them after an investment requires respect for the people and research environment that created the value in the first place.
For international investors, that is the real opportunity: not simply buying at a lower price, but connecting a proven Czech capability with markets, capital and commercial reach it could not build as quickly alone.
How Kodo can support the first steps
Kodo helps international companies understand and prepare their entry into Czechia. For investors and technology businesses, this can include initial market research, mapping relevant companies and partners, local positioning, Czech and English communication, web content, automation and coordination with specialist advisers.
We do not replace legal, tax, financial or technical due diligence. We help make the early commercial questions clearer, connect the necessary work and prepare a credible local presence before a larger commitment is made.
Related reading
- Entering the Czech Market: What International Businesses Should Prepare Before They Launch
- From Taiwan to Czechia: What Semiconductor Companies Should Check Before Choosing a Location
- CzechInvest and CzechTrade Are Becoming CzechBusiness: What Foreign Companies Need to Know
Sources
- Brno University of Technology: Phonexia becomes part of the portfolio of Crescendo Equity Partners
- JIC: Phonexia enters a new growth phase with a new owner
- Phonexia: Company story and current profile
- Phonexia: Current management team
- Phonexia: Partner programme and current product portfolio
This article provides general market and investment information, not legal, tax, financial or investment advice. Companies should conduct appropriate due diligence before making a transaction or market-entry decision.
